Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Fintzi

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Plos One|March 21, 2024
Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccinationAnthony L Guerrerio, Allyson Mateja, Gretchen MacCarrick, et al.
NPJ Vaccines|March 20, 2021
Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicityCarrie M Long, Paul A Beare, Diane C Cockrell, et al.
Environmental Epidemiology (Philadelphia, Pa.)|March 27, 2026
Pulmonary nontuberculous mycobacterial infection is associated with urinary molybdenum concentrations in a bronchiectasis cohortChristopher S Semancik, Alexander Ganninger, Chevalia Robinson, et al.
Emerging Infectious Diseases|August 21, 2020
Mycobacterial Testing Trends, United States, 2009-2015<sup>1</sup>Samantha G Dean, Emily E Ricotta, Jonathan Fintzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2021
Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource UtilizationJonathan Fintzi, Tyler Bonnett, Daniel A Sweeney, et al.
Atmospheric Environment (Oxford, England : 1994)|November 4, 2014
Multi-pollutant mobile platform measurements of air pollutants adjacent to a major roadwayErin A Riley, Lyndsey Banks, Jonathan Fintzi, et al.
The Journal of Clinical Investigation|October 8, 2021
Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent stagingJoana Dias, Giulia Fabozzi, Kylie March, et al.
Arxiv|September 10, 2020
Semi-parametric modeling of SARS-CoV-2 transmission using tests, cases, deaths, and seroprevalence dataDamon Bayer, Isaac H Goldstein, Jonathan Fintzi, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
Open Forum Infectious Diseases|July 12, 2022
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Plos One|March 21, 2024
Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccinationAnthony L Guerrerio, Allyson Mateja, Gretchen MacCarrick, et al.
NPJ Vaccines|March 20, 2021
Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicityCarrie M Long, Paul A Beare, Diane C Cockrell, et al.
Environmental Epidemiology (Philadelphia, Pa.)|March 27, 2026
Pulmonary nontuberculous mycobacterial infection is associated with urinary molybdenum concentrations in a bronchiectasis cohortChristopher S Semancik, Alexander Ganninger, Chevalia Robinson, et al.
Emerging Infectious Diseases|August 21, 2020
Mycobacterial Testing Trends, United States, 2009-2015<sup>1</sup>Samantha G Dean, Emily E Ricotta, Jonathan Fintzi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2021
Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource UtilizationJonathan Fintzi, Tyler Bonnett, Daniel A Sweeney, et al.
Atmospheric Environment (Oxford, England : 1994)|November 4, 2014
Multi-pollutant mobile platform measurements of air pollutants adjacent to a major roadwayErin A Riley, Lyndsey Banks, Jonathan Fintzi, et al.
The Journal of Clinical Investigation|October 8, 2021
Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent stagingJoana Dias, Giulia Fabozzi, Kylie March, et al.
Arxiv|September 10, 2020
Semi-parametric modeling of SARS-CoV-2 transmission using tests, cases, deaths, and seroprevalence dataDamon Bayer, Isaac H Goldstein, Jonathan Fintzi, et al.
The Journal of Infectious Diseases|November 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure Proximal Design but Requires Far Fewer Blood SamplesDean Follmann, Lauren Dang, Eric Chu, et al.
Open Forum Infectious Diseases|July 12, 2022
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2Jonathan Fintzi, Tyler Bonnett, Pablo Tebas, et al.
Pageof 4